Endocrine & Metabolism drugs

111 results

  • addyi

    (flibanserin)
    Sprout Pharmaceuticals, Inc.
    ADDYI is indicated for treating premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD) that causes significant distress and is not linked to medical/psychiatric conditions, relationship issues, or medication effects. It is not approved for postmenopausal women, men, or to enhance sexual performance.

  • admelog

    (insulin lispro)
    Sanofi-Aventis U.S. LLC
    ADMELOG is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

  • afrezza

    (INSULIN HUMAN)
    Mannkind Corporation
    AFREZZA® is a rapid-acting inhaled human insulin for improving glycemic control in adults with diabetes mellitus. It is not recommended for diabetic ketoacidosis and its safety in smokers has not been established.

  • androderm

    (Testosterone)
    Allergan, Inc.
    ANDRODERM is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions affecting testosterone production, such as testicular failure or hormonal deficiencies. Its safety and efficacy in age-related hypogonadism and in males under 18 are not established.

  • androgel

    (Testosterone)
    ASCEND Therapeutics U.S., LLC
    AndroGel 1.62% is indicated for testosterone replacement therapy in adult males with primary or hypogonadotropic hypogonadism due to various conditions. Its safety and efficacy in age-related hypogonadism and in males under 18 have not been established.

  • annovera

    (segesterone acetate and ethinyl estradiol)
    TherapeuticsMD, Inc.
    ANNOVERA is indicated for females of reproductive potential to prevent pregnancy. It is not adequately studied in females with a BMI greater than 29 kg/m².

  • apidra

    (insulin glulisine)
    sanofi-aventis U.S. LLC
    APIDRA is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.

  • atorvaliq

    (ATORVALIQ)
    CMP Pharma, Inc.
    ATORVALIQ is indicated to reduce the risk of cardiovascular events in adults with risk factors for coronary heart disease, type 2 diabetes, and clinically evident coronary heart disease. It also lowers LDL cholesterol in various conditions, including primary hyperlipidemia and familial hypercholesterolemia, as an adjunct to diet or other therapies.

  • aveed

    (testosterone undecanoate)
    ENDO USA, Inc.
    AVEED is indicated for testosterone replacement therapy in adult males with conditions related to testosterone deficiency, including primary and hypogonadotropic hypogonadism. It should only be used when benefits outweigh risks, with safety and efficacy not established for age-related hypogonadism or in males under 18.

  • balcoltra

    (levonorgestrel and ethinyl estradiol)
    Avion Pharmaceuticals
    Balcoltra is indicated for use in females of reproductive potential for the prevention of pregnancy.